Theodore S. Johnson, MD, PhD


Selected Publications

Li M, Bolduc AR, Hoda MN, Gamble DN, Dolisca S, Bolduc AK, Hoang K, Ashley C, McCall D, Rojiani AM, Maria BL, Rixe O, MacDonald TJ, Heeger PS, Mellor AL, Munn DH, Johnson TS. (2014) The indoleamine 2,3-dioxygenase pathway controls complement activation in brain tumors following chemo-radiation therapy. Journal for Immunotherapy of Cancer. 2:21.

Johnson TS, Terrell CE, Millen SH, Katz JD, Hildeman DA, Jordan MB. (2014) Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. Journal of Immunology. 192:84-91.

Johnson TS, Munn DH. (2012) Host Indoleamine 2,3-Dioxygenase: Contribution to Systemic Acquired Tumor Tolerance. Immunological Investigations. 41:765-97.

Johnson TS, Munn DH, Maria BL. (2012) Modulation of Tumor Tolerance in Primary Central Nervous System Malignancies. Clin Dev Immunol.2012:937253.

Johnson TS, Villanueva J, Filipovich AH, Marsh RA, Bleesing JJ. (2011) Contemporary Diagnostic Methods for Hemophagocytic Lymphohistiocytic Disorders. J Immunological Methods. 364:1-13.

Contact Us

Cancer Immunology, Inflammation & Tolerance Program

Health Sciences Campus
M. Bert Storey Research Building
1410 Laney Walker Blvd. CN-4141A Augusta, GA 30912

(706) 721-4962
thjohnson@augusta.edu